Scott Barbour/Getty Images News Shell ( SHEL ) has commenced a $3B share buyback program covering an aggregate contract term of approximately three months. The program is aimed at reducing the issued share capital of the company. The maximum number of ordinary shares that may be purchased by the company under the program is 320M. All shares repurchased as part of the program will be cancelled. The...
Scott Barbour/Getty Images News Shell ( SHEL ) has commenced a $3B share buyback program covering an aggregate contract term of approximately three months. The program is aimed at reducing the issued share capital of the company. The maximum number of ordinary shares that may be purchased by the company under the program is 320M. All shares repurchased as part of the program will be cancelled. The company has entered into an arrangement with a single broker, consisting of one, non-discretionary contract, to enable the purchase of ordinary shares on London market exchanges . The plan is planned to be completed prior to the company’s Q2 results announcement. SHEL down 1.58% premarket. More on Shell Shell Consolidates Its Upstream And LNG Position With ARC Resources Acquisition Shell: Refocusing Will Take Time (Probably A Few Years) Shell: The Company Should Be A Buy, But Near-Term Risks Warrant Patience Shell reports mixed Q1 results; gives Q2 and updates FY26 outlook Shell earnings preview: Q1 profit seen surging 140%, investors weigh Middle East geopolitical risks
If you retire with savings in a traditional IRA or 401(k), you may be looking at a couple of unpleasant things. First, you'll have to pay the IRS taxes on your withdrawals. And while this shouldn't come as a surprise, it can be a nuisance and point of stress. Secondly, with a traditional IRA or 401(k) plan , you can't just let your money grow indefinitely. You'll eventually be forced to take requi...
If you retire with savings in a traditional IRA or 401(k), you may be looking at a couple of unpleasant things. First, you'll have to pay the IRS taxes on your withdrawals. And while this shouldn't come as a surprise, it can be a nuisance and point of stress. Secondly, with a traditional IRA or 401(k) plan , you can't just let your money grow indefinitely. You'll eventually be forced to take required minimum distributions , or RMDs, which could drive up your taxable income and have other unwanted consequences. That's why many people opt to do a Roth conversion ahead of retirement, or early on in retirement before RMDs start. With a Roth conversion , you move funds from a traditional retirement account into a Roth IRA. Continue reading
RPC press release ( RES ): Q1 Non-GAAP EPS of $0.03 in-line. Revenue of $454.8M (+36.6% Y/Y) beats by $48.12M . Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) was $53.5 million, compared to $55.1 million in the prior quarter; Adjusted EBITDA margin decreased 110 basis points sequentially to 11.8%. See Appendix C for additional details More on RPC Seeking Alpha’s Q...
RPC press release ( RES ): Q1 Non-GAAP EPS of $0.03 in-line. Revenue of $454.8M (+36.6% Y/Y) beats by $48.12M . Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) was $53.5 million, compared to $55.1 million in the prior quarter; Adjusted EBITDA margin decreased 110 basis points sequentially to 11.8%. See Appendix C for additional details More on RPC Seeking Alpha’s Quant Rating on RPC Historical earnings data for RPC Dividend scorecard for RPC Financial information for RPC
Stevanato Group press release ( STVN ): Q1 Non-GAAP EPS of € 0.11. Revenue increased 7% (10% on a constant currency basis) to €273.6 million, with high-value solutions representing 47% of total revenue. The Company is maintaining its fiscal 2026 guidance and still expects revenue in the range of €1.26 billion to €1.29 billion, adjusted EBITDA in the range of €331.8 million to €346.9 million, and a...
Stevanato Group press release ( STVN ): Q1 Non-GAAP EPS of € 0.11. Revenue increased 7% (10% on a constant currency basis) to €273.6 million, with high-value solutions representing 47% of total revenue. The Company is maintaining its fiscal 2026 guidance and still expects revenue in the range of €1.26 billion to €1.29 billion, adjusted EBITDA in the range of €331.8 million to €346.9 million, and adjusted diluted EPS in the range of €0.59 to €0.63. More on Stevanato Group Stevanato Group S.p.A. 2025 Q4 - Results - Earnings Call Presentation Stevanato: Strong Q4 Results Reinforce Long-Term Growth Story Stevanato Group S.p.A. (STVN) Q4 2025 Earnings Call Transcript Healthcare quant check: RLAY and TNGX lead Seeking Alpha’s top picks ahead of Q1 earnings Mid-Cap healthcare stocks ranked by quant ratings after earnings season
Krispy Kreme Inc. reported earnings that were broadly in line with estimates and tightened its debt reduction target, signaling its recovery plan is gaining traction. The Charlotte, North Carolina–based company posted adjusted earnings before interest, taxes, depreciation, and amortization of $33.1 million, just ahead of the $30.6 million analyst consensus. The net loss of $22.8 million narrowed f...
Krispy Kreme Inc. reported earnings that were broadly in line with estimates and tightened its debt reduction target, signaling its recovery plan is gaining traction. The Charlotte, North Carolina–based company posted adjusted earnings before interest, taxes, depreciation, and amortization of $33.1 million, just ahead of the $30.6 million analyst consensus. The net loss of $22.8 million narrowed from $33.3 million a year earlier, though missed the $10.8 million loss analysts had predicted. Krispy Kreme now expects a net leverage ratio of less than 5.5 times in 2026 while generating positive cash flow, sharpening prior guidance . The company has been cutting debt and boosting profitability through refranchising, including the sale of its Japan operations and a reduced stake in its Western US joint venture. It plans to refranchise one or two more international businesses this year, and fully outsourced its US logistics as part of cost-cutting efforts. The company forecast 2026 net revenue of $1.25 billion to $1.35 billion, below analyst expectations of $1.46 billion. The company said Wall Street’s estimates don’t yet reflect recent asset sales. “Expansion is still part of our story,” Krispy Kreme Chief Executive Officer Josh Charlesworth said in an interview in light of plans to cut its stake in several businesses. The company plans to open at least 100 new shops this year, almost all likely to be franchised. Krispy Kreme recently entered the Netherlands. It plans to open in three to four new international markets this year. In the US, growth is being driven by sales through third-party retailers like Walmart Inc. and Target Corp. , delivery platforms and its app, Charlesworth said. Softer consumer sentiment hasn’t weighed on demand, he added. Addressing the rise of weight-loss drugs, Charlesworth said the company is focused on offering consumers choice, including smaller portion options like mini doughnuts.
ESAB press release ( ESAB ): Q1 GAAP EPS of $0.78. Revenue of $74.59M. Record total sales increased 10%, with core organic sales down 1% Accelerating ESAB’s compounder journey with equipment Acquisitions outperforming with EWM and Aktiv up double-digits More on ESAB ESAB Corporation: Welder With Ambitions ESAB announces CFO transition ESAB prices $1 billion of 5.625% senior notes due 2031 Seeking ...
ESAB press release ( ESAB ): Q1 GAAP EPS of $0.78. Revenue of $74.59M. Record total sales increased 10%, with core organic sales down 1% Accelerating ESAB’s compounder journey with equipment Acquisitions outperforming with EWM and Aktiv up double-digits More on ESAB ESAB Corporation: Welder With Ambitions ESAB announces CFO transition ESAB prices $1 billion of 5.625% senior notes due 2031 Seeking Alpha’s Quant Rating on ESAB Historical earnings data for ESAB
kim willems/iStock Editorial via Getty Images Back in February, I upgraded Celanese ( CE ) to a buy at around $54, arguing that the deleveraging progress and cost cuts had changed the risk profile enough to get involved despite weak demand. Since then, the stock ran up almost 20% before today's Q1'26 results sent it down about 9% to $62. What led to the drop? The headline numbers were missed. EPS ...
kim willems/iStock Editorial via Getty Images Back in February, I upgraded Celanese ( CE ) to a buy at around $54, arguing that the deleveraging progress and cost cuts had changed the risk profile enough to get involved despite weak demand. Since then, the stock ran up almost 20% before today's Q1'26 results sent it down about 9% to $62. What led to the drop? The headline numbers were missed. EPS looked alarming, free cash flow was weak and the macro backdrop has become a fair bit more complicated than it was three months ago. Driving this has been the Strait of Hormuz crisis that 's created supply chain and cost pressures across the chemical industry. In this article, I 'll contextualize these pieces and how they fit into the latest quarter and explain why the investment case remains intact. The macro backdrop: the Strait of Hormuz matters a lot for Celanese Before getting into the quarter , I think it's important to understand what has happened in the macro environment since my February upgrade. The reason for that is that it is directly relevant to Celanese's results and its forward guidance assumptions. For those who are following the conflict in the Middle East, the Strait of Hormuz has had direct implications for global methanol supply. Before the conflict, about a third of global seaborne methanol trade transited that route. Methanol is one of Celanese's primary acetyl chain feedstocks. European chemical and specialty materials manufacturers (including those that compete in Celanese's core end markets) have been facing energy cost surcharges of up to 30% as the disruption filters through to electricity and feedstock pricing. For Celanese specifically, the Ibn Sina JV in Saudi Arabia (which produces methanol and acetic acid) had most of its assets not operating for approximately six weeks due to shipping constraints and feedstock disruptions (source: Bloomberg). Management guided Ibn Sina's contribution as roughly flat year-over-year, which sounds contained un...
Leggett & Platt press release ( LEG ): Q1 Non-GAAP EPS of $0.15 misses by $0.09 . Revenue of $918M (-8.2% Y/Y) misses by $28.79M . Withdrawing previously issued 2026 guidance due to the pending acquisition by Somnigroup International ( SGI ) More on Leggett & Platt Leggett & Platt: The Somnigroup Merger Is A Decent Exit, But No Bargain Leggett & Platt: This Cigar Butt Doesn't Offer Enough Puffs (D...
Leggett & Platt press release ( LEG ): Q1 Non-GAAP EPS of $0.15 misses by $0.09 . Revenue of $918M (-8.2% Y/Y) misses by $28.79M . Withdrawing previously issued 2026 guidance due to the pending acquisition by Somnigroup International ( SGI ) More on Leggett & Platt Leggett & Platt: The Somnigroup Merger Is A Decent Exit, But No Bargain Leggett & Platt: This Cigar Butt Doesn't Offer Enough Puffs (Downgrade) Leggett & Platt, Incorporated (LEG) Q4 2025 Earnings Call Transcript Leggett & Platt Q1 2026 Earnings Preview Key deals this week: American Express, Otis, Vertiv, Wipro and more
Nuvalent press release ( NUVL ): Q1 GAAP EPS of -$1.39. Cash, cash equivalents and marketable securities were $1.3 billion as of March 31, 2026. Nuvalent continues to believe that its existing cash, cash equivalents and marketable securities will be sufficient to fund its operations into 2029. More on Nuvalent Nuvalent: A Precision Oncology Platform With Two Near-Term Shots On Goal Seeking Alpha’s...
Nuvalent press release ( NUVL ): Q1 GAAP EPS of -$1.39. Cash, cash equivalents and marketable securities were $1.3 billion as of March 31, 2026. Nuvalent continues to believe that its existing cash, cash equivalents and marketable securities will be sufficient to fund its operations into 2029. More on Nuvalent Nuvalent: A Precision Oncology Platform With Two Near-Term Shots On Goal Seeking Alpha’s Quant Rating on Nuvalent Historical earnings data for Nuvalent Financial information for Nuvalent